Last reviewed · How we verify
NCT04380259
Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)
Phase 1, PHASE2 trial testing Mindfulness-Based Trauma Recovery for Refugees (MBTR-R) in Stress Disorders, Post-Traumatic in 158 participants. Completed in 18 May 2019.
18 May 2019
Quick facts
| Lead sponsor | University of Haifa |
|---|---|
| Phase | Phase 1, PHASE2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 158 |
| Start date | 10 May 2018 |
| Primary completion | 18 May 2019 |
| Estimated completion | 18 May 2019 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)
Conditions studied
- Stress Disorders, Post-Traumatic — all drugs for Stress Disorders, Post-Traumatic →
- Stress Related Disorder — all drugs for Stress Related Disorder →
Sponsor
University of Haifa
Who can join
Adults 18 to 65, any sex, with Stress Disorders, Post-Traumatic or Stress Related Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Worldwide, refugees and asylum seekers suffer at high rates from trauma- and stress-related mental health problems. The investigators thus developed Mindfulness-Based Trauma Recovery for Refugees (MBTR-R) - a 9-week, mindfulness- and compassion-based, trauma-sensitive and socio-culturally adapted, group intervention for refugees and asylum seekers. The overarching aims of the study were to, first, test whether MBTR-R is an efficacious and safe mental health intervention for traumatized refugees and asylum seekers with respect to stress- and trauma-related mental health outcomes; and, second, to test theorized mechanisms of action of MBTR-R. Accordingly, the investigators conducted a randomized waitlist-controlled trial among a community sample of female and male Eritrean asylum seekers in an urban post-displacement setting in the Middle East (Israel).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevalence and prevention of suicidal ideation among asylum seekers in a high-risk urban post-displacement setting.
Aizik-Reebs A, Yuval K, Beyene Kesete Y, Lurie I, et al · · 2022 · cited 5× · PMID 36245417 · DOI 10.1017/s2045796022000579
Verify or expand the search:
- PubMed search for NCT04380259
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stress Disorders, Post-Traumatic
Currently open trials in the same condition.
- NCT07422077 — Impact of ERCS on Perceived Stress in Patients Hospitalized in the Post-resuscitation Rehabilitation Service · NA · recruiting
- NCT07010770 — SMART Therapist Training: A Hybrid Factorial-SMART Design · NA · recruiting
- NCT06852469 — Computational Assessment of GABA Receptor Modulation in PTSD · Phase 4 · recruiting
- NCT06000475 — Enhancing Memory in CPT for PTSD · NA · recruiting
- NCT06355284 — Overcontrol and Suicide in PTSD · active not recruiting
Other University of Haifa trials
Trials by the same sponsor.
- NCT07379801 — The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program · NA · recruiting
- NCT07325929 — Online Radical Acceptance Intervention for Social Anxiety Disorder · NA · not yet recruiting
- NCT06749392 — An Individual-specific Synchrony Signature · NA · recruiting
- NCT07367763 — The Relationship Between Self-Awareness and Risk of Falls During Walking in Adults · active not recruiting
- NCT06932679 — Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04380259 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Haifa
- Last refreshed: 8 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04380259.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing